Back With A Bang: ‘Brexit Bill’ For UK’s Medical Devices Due For 2nd Reading On 2 March
The process of regulating for a future outside the EU gets fully underway in the UK parliament
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
You may also be interested in...
UK Devices Bill Back On The Agenda As Govt Tries To Get COVID-19 Crisis Under Control
Post-Brexit planning is now fully back on the agenda in the UK, and work to shape its post-EU medtech regulatory future is also restarting.
UK Devices Bill Offers Medtech An EU MDR Alternative – Or Better?
With the obvious distractions of coronavirus, the UK Medicines and Medical Devices bill has entered its second reading in parliament, accompanied by a drive for it to succeed from the government and opposition parties.
UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.